Globeways Holdings Ltd

10% owner at MPM ACQUISITION CORP · on record since Feb 21, 2014
10% owner at CHIASMA, INC · on record since Jul 17, 2015
10% owner at TCR2 THERAPEUTICS INC. · on record since Feb 21, 2019
10% owner at Cullinan Therapeutics, Inc. · on record since Jan 14, 2021
Director at Kalaris Therapeutics, Inc. · on record since Aug 5, 2022
10% owner at Kalaris Therapeutics, Inc. · on record since Aug 5, 2022

Insider trading activity of Globeways Holdings Ltd

No transactions on record for Globeways Holdings Ltd.

Track record of Globeways Holdings Ltd

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Globeways Holdings Ltd

Co-insiders of Globeways Holdings Ltd

GADICKE ANSBERTCHIASMA, INC +4
Jovan-Embiricos MoranaCullinan Therapeutics, Inc. +3
EVNIN LUKECHIASMA, INC +2
F2 MG LtdCullinan Therapeutics, Inc. +2
F2 - TPO Investments LLCCullinan Therapeutics, Inc. +2
Foley ToddCHIASMA, INC +2
Allen Andrew RCullinan Therapeutics, Inc. +1
Baeuerle PatrickCullinan Therapeutics, Inc. +1
F2 MC, LLCCullinan Therapeutics, Inc. +1
Globeways Holdings II LtdKalaris Therapeutics, Inc. +1
Green JeremyKalaris Therapeutics, Inc. +1
Hughes OwenCullinan Therapeutics, Inc. +1
KAILIAN VAUGHN MCHIASMA, INC +1
MPM Bio IV NVS Strategic Fund LPCHIASMA, INC +1
MPM BioVentures IV GP LLCCHIASMA, INC +1
MPM BioVentures IV LLCCHIASMA, INC +1
MPM Oncology Impact Management GP LLCCullinan Therapeutics, Inc. +1
MPM Oncology Impact Management LPCullinan Therapeutics, Inc. +1
Oncology Impact Fund (Cayman) Management L.P.Cullinan Therapeutics, Inc. +1
Redmile Group, LLCKalaris Therapeutics, Inc. +1
Rosenberg AnthonyCullinan Therapeutics, Inc. +1
Scopa James PaulCHIASMA, INC +1
Tomasello ShawnKalaris Therapeutics, Inc. +1
UBS Oncology Impact Fund L.P.Cullinan Therapeutics, Inc. +1
Webster Stephen WCullinan Therapeutics, Inc. +1
7-MED Health Ventures LPCHIASMA, INC
Abingworth LLPCHIASMA, INC
ADAMIS ANTHONY PKalaris Therapeutics, Inc.
Adams Derek N.Kalaris Therapeutics, Inc.
Adler Lundgren Tamara L.MPM ACQUISITION CORP
AHMED NADIMCullinan Therapeutics, Inc.
AKKARAJU SRINIVASKalaris Therapeutics, Inc.
Atillasoy ErcemKalaris Therapeutics, Inc.
AUERBACH ALAN HMPM ACQUISITION CORP
BB BIOTECH AGMPM ACQUISITION CORP
BIOTECH GROWTH N VMPM ACQUISITION CORP
BIOTECHNOLOGY VALUE FUND II LPCullinan Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND L PCullinan Therapeutics, Inc.
Biotechnology Value Trading Fund OS LPCullinan Therapeutics, Inc.
BIOTECH TARGET N VMPM ACQUISITION CORP
Bornstein Jeffrey SKalaris Therapeutics, Inc.
Brainard DianaKalaris Therapeutics, Inc.
BRENNER LOUIS MDMPM ACQUISITION CORP
Brenner MalcolmKalaris Therapeutics, Inc.
BROOKSIDE CAPITAL INVESTORS L PMPM ACQUISITION CORP
BROOKSIDE CAPITAL MANAGEMENT LLCMPM ACQUISITION CORP
BROOKSIDE CAPITAL PARTNERS FUND LPMPM ACQUISITION CORP
BVF GP HOLDINGS LLCCullinan Therapeutics, Inc.
BVF I GP LLCCullinan Therapeutics, Inc.
BVF II GP LLCCullinan Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →